199 related articles for article (PubMed ID: 31894409)
1. Point of Care Portable Spirometry in the Diagnosis and Treatment of Inpatients with Chronic Obstructive Pulmonary Disease.
Tran D; Lim M; Vogrin S; Jayaram L
Lung; 2020 Feb; 198(1):143-150. PubMed ID: 31894409
[TBL] [Abstract][Full Text] [Related]
2. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
[TBL] [Abstract][Full Text] [Related]
3. Inaccurate diagnosis of COPD: the Welsh National COPD Audit.
Fisk M; McMillan V; Brown J; Holzhauer-Barrie J; Khan MS; Baxter N; Roberts CM
Br J Gen Pract; 2019 Jan; 69(678):e1-e7. PubMed ID: 30559109
[TBL] [Abstract][Full Text] [Related]
4. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
[TBL] [Abstract][Full Text] [Related]
5. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
7. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
[TBL] [Abstract][Full Text] [Related]
8. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
[TBL] [Abstract][Full Text] [Related]
9. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
10. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
Petite SE
Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
[TBL] [Abstract][Full Text] [Related]
11. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
12. Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE.
Saito T; Takeda A; Hashimoto K; Kobayashi A; Hayamizu T; Hagan GW
Int J Chron Obstruct Pulmon Dis; 2015; 10():2393-404. PubMed ID: 26604737
[TBL] [Abstract][Full Text] [Related]
13. Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease.
Rodriguez-Roisin R; Tetzlaff K; Watz H; Wouters EF; Disse B; Finnigan H; Magnussen H; Calverley PM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1973-81. PubMed ID: 27578972
[TBL] [Abstract][Full Text] [Related]
14. Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population.
Ghattas C; Dai A; Gemmel DJ; Awad MH
Int J Chron Obstruct Pulmon Dis; 2013; 8():545-9. PubMed ID: 24348030
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
16. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
Manoharan A; Morrison AE; Lipworth BJ
Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
[TBL] [Abstract][Full Text] [Related]
17. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD.
Rea H; Kenealy T; Adair J; Robinson E; Sheridan N
Int J Chron Obstruct Pulmon Dis; 2011; 6():527-32. PubMed ID: 22069364
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
19. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study.
Dahl R; Chapman KR; Rudolf M; Mehta R; Kho P; Alagappan VK; Chen H; Banerji D
Respir Med; 2013 Oct; 107(10):1558-67. PubMed ID: 23867808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
